ALR TECHNOLOGIES TO RELAUNCH THE GLUCURVE PET CGM IN JANUARY 2026

Core Viewpoint - ALR Technologies SG Ltd has successfully completed internal manufacturing testing of the GluCurve Pet CGM, which is set to relaunch in the Canadian market in January 2026, demonstrating accuracy comparable to leading veterinary Blood Glucose Meters [1][4]. Product Overview - GluCurve is the first diabetic monitoring system specifically designed for veterinary use on cats and dogs, providing blood sugar readings every 3 minutes for up to 14 days through a pain-free sensor [2]. - The GluCurve Pet CGM app allows pet owners to view blood sugar levels, while data is also uploaded to the ALRT Veterinary Web Portal for veterinarians to manage patient care [2]. Market Potential - The estimated market size for GluCurve is projected to be between 150,000-300,000 units annually in Canada, 2,000,000-3,000,000 units in the United States, and another 2,000,000-3,000,000 units in Europe [3]. - The need for a continuous glucose monitoring solution for pets is emphasized, as traditional methods are inadequate for proper insulin dosing and trend analysis [3]. Manufacturing and Partnerships - ALRT is collaborating with CGM Medical Technology Shenzhen Ltd for the manufacturing of GluCurve units and the development of a human market CGM [4]. - The company has been enhancing manufacturing capabilities at the Foxconn facility in Shenzhen, nearing the launch of the improved GluCurve Pet CGM [4]. Distribution Plans - Veterinary clinics in Canada will be able to order GluCurve directly from the official website, with plans for a U.S. relaunch in early Q2 2026 through a strategic partnership with a leading veterinary distributor [5]. - A global launch is planned for Europe, Australia, Asia, South America, and other regions following the initial relaunch [5]. Company Background - ALR Technologies SG Ltd is a data management company focused on diabetes care, offering a comprehensive diabetes management system that includes a predictive A1C algorithm and an insulin dosing adjustment program [7]. - The animal health division aims to optimize diabetic drug therapies for pets, similar to those for humans, through the GluCurve Pet CGM [8].